{"id":"NCT01144299","sponsor":"GlaxoSmithKline","briefTitle":"A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults","officialTitle":"A Phase III Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™/Influsplit SSW® 2010/2011 in People Aged 18 Years or Above","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-06-17","primaryCompletion":"2010-07-10","completion":"2010-07-10","firstPosted":"2010-06-15","resultsPosted":"2010-10-27","lastUpdate":"2018-09-24"},"enrollment":114,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"Fluarix™/Influsplit SSW®","otherNames":[]}],"arms":[{"label":"Fluarix Adult Group","type":"EXPERIMENTAL"},{"label":"Fluarix Elderly Group","type":"EXPERIMENTAL"}],"summary":"This study is designed to test the immunogenicity and reactogenicity of the Fluarix™/Influsplit SSW® influenza vaccine containing the influenza strains recommended for the 2010-2011 season.","primaryOutcome":{"measure":"Hemagglutination Inhibition (HI) Antibody Titer","timeFrame":"Day 0 and Day 21","effectByArm":[{"arm":"Fluarix Adult Group","deltaMin":10.2,"sd":null},{"arm":"Fluarix Elderly Group","deltaMin":8.7,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":14},"locations":{"siteCount":6,"countries":["Germany"]},"refs":{"pmids":[],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":60},"commonTop":["Pain","Redness","Fatigue","Headache","Myalgia"]}}